Market Closed -
Nasdaq
01:30:00 27/04/2024 am IST
|
5-day change
|
1st Jan Change
|
17.7
USD
|
+0.57%
|
|
-2.96%
|
-32.21%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46,232
|
32,946
|
43,898
|
30,301
|
21,849
|
15,270
|
-
|
-
|
Enterprise Value (EV)
1 |
62,045
|
48,668
|
51,685
|
39,503
|
30,172
|
22,472
|
22,077
|
21,241
|
P/E ratio
|
11.9
x
|
73.1
x
|
17.3
x
|
7
x
|
-7.09
x
|
-2.12
x
|
8.32
x
|
7.23
x
|
Yield
|
3.47%
|
4.92%
|
3.7%
|
5.45%
|
-
|
7.6%
|
5.95%
|
7.28%
|
Capitalization / Revenue
|
0.34
x
|
0.24
x
|
0.33
x
|
0.23
x
|
0.16
x
|
0.11
x
|
0.1
x
|
0.1
x
|
EV / Revenue
|
0.45
x
|
0.35
x
|
0.39
x
|
0.3
x
|
0.22
x
|
0.15
x
|
0.15
x
|
0.14
x
|
EV / EBITDA
|
7.37
x
|
6.82
x
|
7.87
x
|
6.3
x
|
6.03
x
|
4.59
x
|
4.2
x
|
3.42
x
|
EV / FCF
|
15.9
x
|
11.8
x
|
12.4
x
|
18.2
x
|
214
x
|
16
x
|
9.66
x
|
7.85
x
|
FCF Yield
|
6.27%
|
8.45%
|
8.08%
|
5.48%
|
0.47%
|
6.25%
|
10.4%
|
12.7%
|
Price to Book
|
1.95
x
|
1.59
x
|
1.84
x
|
1.03
x
|
0.77
x
|
1.03
x
|
0.98
x
|
0.86
x
|
Nbr of stocks (in thousands)
|
9,03,143
|
8,66,534
|
8,64,987
|
8,64,257
|
8,63,261
|
8,62,713
|
-
|
-
|
Reference price
2 |
51.19
|
38.02
|
50.75
|
35.06
|
25.31
|
17.70
|
17.70
|
17.70
|
Announcement Date
|
28/10/19
|
15/10/20
|
14/10/21
|
13/10/22
|
12/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,36,866
|
1,39,537
|
1,32,509
|
1,32,703
|
1,39,081
|
1,45,315
|
1,50,911
|
1,57,307
|
EBITDA
1 |
8,413
|
7,138
|
6,567
|
6,268
|
5,002
|
4,901
|
5,253
|
6,217
|
EBIT
1 |
6,942
|
5,211
|
5,117
|
5,133
|
3,871
|
3,067
|
3,531
|
3,954
|
Operating Margin
|
5.07%
|
3.73%
|
3.86%
|
3.87%
|
2.78%
|
2.11%
|
2.34%
|
2.51%
|
Earnings before Tax (EBT)
1 |
4,527
|
743
|
1,995
|
3,985
|
-5,419
|
-12,897
|
1,562
|
1,333
|
Net income
1 |
3,982
|
456
|
2,542
|
4,337
|
-3,080
|
-7,156
|
1,955
|
2,243
|
Net margin
|
2.91%
|
0.33%
|
1.92%
|
3.27%
|
-2.21%
|
-4.92%
|
1.3%
|
1.43%
|
EPS
2 |
4.310
|
0.5200
|
2.930
|
5.010
|
-3.570
|
-8.349
|
2.127
|
2.449
|
Free Cash Flow
1 |
3,892
|
4,111
|
4,176
|
2,165
|
141
|
1,404
|
2,285
|
2,704
|
FCF margin
|
2.84%
|
2.95%
|
3.15%
|
1.63%
|
0.1%
|
0.97%
|
1.51%
|
1.72%
|
FCF Conversion (EBITDA)
|
46.26%
|
57.59%
|
63.59%
|
34.54%
|
2.82%
|
28.65%
|
43.5%
|
43.5%
|
FCF Conversion (Net income)
|
97.74%
|
901.54%
|
164.28%
|
49.92%
|
-
|
-
|
116.86%
|
120.57%
|
Dividend per Share
2 |
1.778
|
1.870
|
1.880
|
1.912
|
-
|
1.345
|
1.054
|
1.289
|
Announcement Date
|
28/10/19
|
15/10/20
|
14/10/21
|
13/10/22
|
12/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Net sales
1 |
33,901
|
33,756
|
32,597
|
32,449
|
33,382
|
34,862
|
35,415
|
35,422
|
36,707
|
37,052
|
35,970
|
36,076
|
37,764
|
37,899
|
37,613
|
EBITDA
1 |
2,277
|
1,931
|
1,232
|
993
|
1,510
|
1,774
|
1,556
|
1,013
|
1,028
|
1,244
|
1,117
|
1,098
|
1,223
|
1,389
|
1,238
|
EBIT
1 |
1,777
|
1,657
|
955
|
744
|
1,014
|
1,215
|
959
|
683
|
687
|
900
|
746.5
|
732.6
|
838.3
|
1,046
|
950.8
|
Operating Margin
|
5.24%
|
4.91%
|
2.93%
|
2.29%
|
3.04%
|
3.49%
|
2.71%
|
1.93%
|
1.87%
|
2.43%
|
2.08%
|
2.03%
|
2.22%
|
2.76%
|
2.53%
|
Earnings before Tax (EBT)
1 |
3,814
|
947
|
-18
|
-758
|
-5,270
|
607
|
-382
|
-375
|
-358
|
-13,114
|
345
|
290.3
|
441.7
|
597.7
|
557.7
|
Net income
1 |
3,580
|
883
|
289
|
-415
|
-3,721
|
703
|
118
|
-180
|
-67
|
-5,908
|
241.1
|
244.8
|
362.6
|
515.6
|
463.2
|
Net margin
|
10.56%
|
2.62%
|
0.89%
|
-1.28%
|
-11.15%
|
2.02%
|
0.33%
|
-0.51%
|
-0.18%
|
-15.95%
|
0.67%
|
0.68%
|
0.96%
|
1.36%
|
1.23%
|
EPS
2 |
4.130
|
1.020
|
0.3300
|
-0.4800
|
-4.310
|
0.8100
|
0.1400
|
-0.2100
|
-0.0800
|
-6.850
|
0.2772
|
0.2898
|
0.3840
|
0.5659
|
0.5021
|
Dividend per Share
2 |
0.4775
|
0.4775
|
0.4775
|
0.4800
|
0.4800
|
-
|
0.4800
|
-
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.3638
|
0.2500
|
Announcement Date
|
06/01/22
|
31/03/22
|
30/06/22
|
13/10/22
|
05/01/23
|
28/03/23
|
27/06/23
|
12/10/23
|
04/01/24
|
28/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,813
|
15,722
|
7,787
|
9,202
|
8,323
|
7,202
|
6,807
|
5,971
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.88
x
|
2.203
x
|
1.186
x
|
1.468
x
|
1.664
x
|
1.47
x
|
1.296
x
|
0.9604
x
|
Free Cash Flow
1 |
3,892
|
4,111
|
4,176
|
2,165
|
141
|
1,404
|
2,285
|
2,704
|
ROE (net income / shareholders' equity)
|
22.3%
|
18.9%
|
20.5%
|
16.4%
|
11.9%
|
13.8%
|
19%
|
19.7%
|
ROA (Net income/ Total Assets)
|
5.87%
|
0.59%
|
5.46%
|
5.06%
|
3.68%
|
-9.79%
|
2.02%
|
2.6%
|
Assets
1 |
67,861
|
77,380
|
46,566
|
85,705
|
-83,627
|
73,068
|
96,845
|
86,263
|
Book Value Per Share
2 |
26.30
|
23.80
|
27.50
|
34.00
|
32.80
|
17.10
|
18.10
|
20.50
|
Cash Flow per Share
2 |
6.060
|
6.230
|
6.410
|
4.500
|
2.620
|
4.320
|
4.550
|
4.530
|
Capex
1 |
1,702
|
1,374
|
1,379
|
1,734
|
2,117
|
1,544
|
1,614
|
1,686
|
Capex / Sales
|
1.24%
|
0.98%
|
1.04%
|
1.31%
|
1.52%
|
1.06%
|
1.07%
|
1.07%
|
Announcement Date
|
28/10/19
|
15/10/20
|
14/10/21
|
13/10/22
|
12/10/23
|
-
|
-
|
-
|
Last Close Price
17.7
USD Average target price
23.1
USD Spread / Average Target +30.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -32.21% | 15.27B | | -31.97% | 10.84B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -30.42% | 6.06B | | -0.88% | 4.71B | | +52.19% | 4.29B | | -12.31% | 3.61B | | -14.86% | 3.33B | | -6.93% | 3.01B |
Other Drug Retailers
|